Osaka Medical Center, Osaka, Japan
Researchers' findings from Japan and Germany advance cancer treatment research
Published in Law and Health Weekly, October 14th, 2006
Study 1: A recent publication from Japan has chronicled a prospective randomized trial of natural interferon-alpha versus natural interferon-alpha plus cimetidine in advanced renal cell carcinoma with pulmonary metastasis.
"In a preliminary non-randomized study, combination therapy with natural (i.e. non-recombinant) interferon-alpha plus cimetidine obtained a high response rate in patients with advanced renal cell carcinoma.
"We conducted a prospective randomized phase III trial to determine whether combination therapy with natural interferon-alpha plus...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Amphora Discovery
Amphora Discovery forms two market-driven business units - Center Hospital Pitie Salpetriere, Paris, France
Researchers from France, the United States and the United Kingdom provide details of new studies and findings in the area of HIV/AIDS - Community Oncology Alliance
Cancer community gathers on Capitol Hill to save cancer care - Identa
Drug detection products made by IDenta earn acceptance of Chinese Federal Police - Indiana University, U.S.
Bioethics program in predictive health is established at Indiana University - Inex Pharmaceuticals
INEX receives Protiva Biotherapeutics' statement of claim - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
